scholarly journals Serum protein profiling in mice: Identification of Factor XIIIa as a potential biomarker for muscular dystrophy

PROTEOMICS ◽  
2008 ◽  
Vol 8 (8) ◽  
pp. 1552-1563 ◽  
Author(s):  
Sharmini Alagaratnam ◽  
Bart J. A. Mertens ◽  
Johannes C. Dalebout ◽  
André M. Deelder ◽  
Gert-Jan B. van Ommen ◽  
...  
Author(s):  
Marina Rieder ◽  
Luisa Wirth ◽  
Luisa Pollmeier ◽  
Maren Jeserich ◽  
Isabella Goller ◽  
...  

Abstract Background Severe courses of COVID-19 are associated with elevated levels of interleukin 6. However, there is a growing body of evidence pointing to a broad and more complex disorder of pro-inflammatory and anti-viral responses with disturbed interferon signaling in COVID-19. Methods In this prospective single-center registry, we included SARS-CoV-2 positive patients and patients with similar symptoms and severity of disease but negative for SARS-CoV-2 admitted to the emergency department and compared their serum protein expression profiles. Results Interleukin-6 abundance was similar in SARS-CoV-2 positive patients (n = 24) compared to SARS-CoV-2 negative control (n = 61). In contrast, we observed a specific upregulation of the immunomodulatory protein progranulin (GRN). High GRN abundance was associated with adverse outcomes and increased expression of interleukin-6 in COVID-19. Conclusion The data from this registry reveals that GRN is specifically upregulated in SARS-CoV-2 positive patients while interleukin-6 may serve as marker for disease severity. The potential of GRN as a biomarker and a possible impact of increased GRN expression on interferon signaling, virus elimination, and virus-induced lung tissue damage in COVID-19 should be further explored.


2009 ◽  
Vol 136 (5) ◽  
pp. A-194
Author(s):  
Nicola C. Hare ◽  
Margaret Imrie ◽  
Kimberley Soo ◽  
Amanda Smith ◽  
Robert Gray ◽  
...  

Hepatology ◽  
2004 ◽  
Vol 41 (1) ◽  
pp. 40-47 ◽  
Author(s):  
Valérie Paradis ◽  
Francoise Degos ◽  
Delphine Dargère ◽  
Nanou Pham ◽  
Jacques Belghiti ◽  
...  

2009 ◽  
Vol 7 (2) ◽  
pp. 313-314
Author(s):  
W.E. Mesker ◽  
B.J. Mertens ◽  
Y.E.M. van der Burgt ◽  
A.M. Deelder ◽  
R.A.E.M. Tollenaar

2008 ◽  
Vol 1 (1) ◽  
Author(s):  
Marie-Christine W Gast ◽  
Judith YMN Engwegen ◽  
Jan HM Schellens ◽  
Jos H Beijnen

Lung ◽  
2009 ◽  
Vol 188 (1) ◽  
pp. 15-23 ◽  
Author(s):  
Qi Liu ◽  
Xuerong Chen ◽  
Chaojun Hu ◽  
Renqing Zhang ◽  
Ji Yue ◽  
...  

2009 ◽  
Vol 28 (4) ◽  
pp. 274-278 ◽  
Author(s):  
Olgica Trenčevska ◽  
Vasko Aleksovski ◽  
Kiro Stojanoski

Advanced Techniques in Clinical Practice: Use of Lab-on-a-Chip Electrophoresis and Other Methods in Protein ProfilingProteins in clinical practice are analyzed as important parameters in the determination and treatment of different diseases. The scopes of the analyses are mainly concentrated in two levels - analyses of the complete protein profile, or determination of an isolated protein. In this work, despite of the use of conventional methods, mainly electrophoresis, new techniques have been implemented in protein analyses. Lab-on-a-chip is an electrophoretic technique that, when optimized, provides analyses of the total protein profile. When normal samples are compared to samples obtained from patients with different neurological diseases, characteristic patterns can be noted. Also, correlation and comparison can be made between the newly developed microchip electrophoresis method and the results obtained using the conventional techniques. When an analysis of a specific protein is necessary, mass spectrometry has proven to give best results, in both the se lectivity and specificity of analyses. It is believed that cystatin C is a potential biomarker in neurological diseases; therefore, the mass spectrometry method has been developed in order to obtain qualitative and quantitative analyses of biological fluids. Using the developed method of mass spectrometry immunoassay (MSIA), cystatin C was easily isolated and analyzed, obtaining complete analysis within minutes. The resulting mass spectra revealed various levels of cystatin C isoforms in serum and CSF samples.


Cancer ◽  
2006 ◽  
Vol 107 (1) ◽  
pp. 99-107 ◽  
Author(s):  
David Wing Yuen Ho ◽  
Zhen Fan Yang ◽  
Birgitta Yee-Hang Wong ◽  
Dora Lai-Wan Kwong ◽  
Jonathan Shun-Tong Sham ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document